Latest Articles
-
Get Paid 18% A Year To Cap Your ANET Stock At 21% Higher
Here is a way to get paid a real income now on your Arista Networks shares, cash you keep no matter what, in exchange for capping your gains at a price above today’s. Arista Networks (ANET) has been on a spectacular run, climbing 45% in j...
-
The Peer-Group Mispricing Sitting On LOW Stock
In the home improvement aisle, one giant’s performance metrics are climbing while its stock price lags the broader market, asking investors to decide if it’s a bargain or a trap. Lowe’s Companies (LOW) stock is trading around ...
-
What HD Holders Got Paid While The Stock Fell Behind
Home Depot sent its owners a torrent of cash, yet the stock trailed the market. Here is the accounting of what that trade-off actually bought, and what it means now. For an investor focused on cash returns, owning Home Depot (HD) presents a para...
-
ONON Has Bounced From This Price Before. Now What?
After a sharp drop, a premium shoemaker’s stock has landed on a floor that has held five times before, forcing investors to ask if the business arriving this time is strong enough to hold the line again. For anyone holding On (ONON) stock, the q...
-
The Market Is Paying You To Own MELI. Why?
The market is offering a Latin American e-commerce giant at a steep cash discount, but the price tag comes with a serious question about the cost of growth. MercadoLibre (MELI), Latin America’s e-commerce and payments operator, currently ...
-
The Debates That Matter For KO Stock
Coca-Cola’s powerful results met with pointed questions about whether the good times can last, and management’s answers revealed where the real tests lie for the second half. After a year of outperforming the broader market, Coca-Col...
-
The Paid-To-Hold Play On ISRG Stock: A 12% Annualized Income
Get paid a real income now on your Intuitive Surgical shares—income you keep no matter what—in exchange for agreeing to sell at a higher price if the stock gets there. Intuitive Surgical (ISRG) has been a frustrating stock to own lately, tradin...
-
How ABBV Stock Moved Away From Its Peer Group
The drugmaker’s operating numbers are near the top of its class, but its stock performance is lagging the pack. Is the market seeing a risk that the fundamentals are missing? In the world of big pharma, AbbVie (ABBV) ’s stock is a puzzle. ...
-
CRM Stock Passed Our Value-Trap Test. Now What?
After a steep fall from its highs, Salesforce looks cheap next to the market, forcing investors to decide if the software giant is a bargain or a broken business. Salesforce (CRM), the dominant force in customer relationship management software...
-
EBAY Stock: Where Compounding Could Take The Price
While the market sees a legacy platform, a newer eBay is emerging from within. The company’s focused categories, from luxury goods to auto parts, are quietly becoming the core business. This specific segment grew 26% last quarter and for th...
-
Amgen Stock And The Price Of A Promise
Management raised its full-year forecast, but the market seems to be asking for more than a higher target. On Aug 4, 2026, Amgen (AMGN) ’s management did what investors love to see: they raised their full-year revenue guidance . It’s a public de...
-
Why Seneca Foods Looks Ripe For A Takeover
This cash-gushing food producer has a clean balance sheet and dispersed ownership, putting it squarely on the menu for a specific set of buyers. You’ve probably walked past its products in the grocery aisle a hundred times without a second thoug...
-
How Far Can Arista Stock Move Without Anything Going Wrong?
The band the options market prices for the next ten months runs from just under the low this stock has set over the past year to a level far above today’s price, and the volatility behind it is close to what the stock has actually been doin...
-
Accenture Stock Trades At A Discount While The Company Buys Its Growth
What the market is paying less for in Accenture stock, and what the company is spending nine billion dollars to change. Accenture (ACN) is down about 24% over the past year, and the stock trades at 14.1 times earnings against 23.7 times for the...
-
Rocket Lab Stock Sold Off While Its Operating Margin Kept Climbing
Cash burn and a softer gross-margin guide have added to a slide that leaves the stock well below its high, yet its operating loss per dollar of revenue has narrowed in each of the last three years. Rocket Lab (RKLB) trades at $80.01, roughly 53...
